Height as a substitute for weight for estimating praziquantel dosage

E T Idowu1, M A Mafe, B Appelt

  • 1Public Health Division, Nigerian Institute of Medical Research, P.M.B. 2013, Yaba, Lagos, Nigeria. etidowu@yahoo.com

World Health & Population
|February 15, 2008
PubMed

Insights

Community health workers can accurately measure child weight and height for Praziquantel dosing in Nigeria. Height measurements by distributors correlate well with research team data, supporting its use for dose determination.

Area of Science:

  • Pediatrics
  • Public Health
  • Tropical Medicine

Background:

  • Accurate anthropometric measurements are crucial for pediatric drug dosing, particularly in resource-limited settings.
  • Praziquantel is a key anthelmintic medication used in mass drug administration programs for schistosomiasis control.
  • Community health workers (CHWs) are integral to the delivery of public health interventions in rural areas.

Purpose of the Study:

  • To assess the reliability of anthropometric measurements (height and weight) taken by trained community distributors for pediatric Praziquantel dose determination.
  • To evaluate the correlation between measurements taken by community distributors and a research team.

Main Methods:

  • 750 school children from five rural Nigerian communities were included.
  • Trained community members (distributors) took height and weight measurements.
  • Measurements were compared against those taken by a research team to determine correlation coefficients.

Main Results:

  • A strong correlation (r=0.97) was found for weight measurements between distributors and the research team.
  • A significant correlation (r=0.87) was observed for combined weight and height measurements.
  • Height measurements demonstrated potential utility for dose determination by community distributors.

Conclusions:

  • Trained community distributors can reliably measure child weight for Praziquantel dosing.
  • Child height measurements show promise as a viable alternative to weight for accurate Praziquantel dose determination in Nigerian rural communities.
  • This finding supports the integration of height-based dosing protocols to enhance public health interventions delivered by CHWs.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...